01 July 2005 : Extended abstract from EFAS 2011
The molecular characterization of clinical isolates from Indian Kala-azar patientsby MLEE and RAPD-PCR.
Madhumita Manna, Hemanta Kumar Majumder, Shyam Sundar, Amar Nath BhaduriMed Sci Monit 2005; 11(7): BR220-227 :: ID: 16974
Abstract
Background: Kala-azar is a serious health problem in India. The situationhas worsened further due to the occurrence of cases unresponsive to antimonials. About 30-50% patientsdo not respond to the prevailing regimen of antimonials. The etiological agent for Indian kala-azar haslong been known to be Leishmania donovani. Recently, in a somewhat startling report, it was claimed thatL. Tropica causes nearly 25% of current kala-azar cases in India. It was also suggested that this mightbe in some way related to the unresponsiveness to pentavalent antimonials in the field. Material/Methods:Two independent molecular characterization techniques, multilocus enzyme electrophoresis (MLEE) and RAPD-PCR,were employed to analyze 15 clinical isolates from confirmed Indian kala-azar patients collected fromthe eastern part of the country over a period of nearly 20 years. The collection included six Sb(5+)-unresponsiveand one PKDL case. Results: Our observations strongly suggest that all the clinical isolates, includingthe antimony (Sb(5+))-unresponsive and PKDL ones, we studied were identical to the WHO reference strain(DD8) for Leishmania donovani by both the above methods and no strain variation might have occurred intwo major epidemic and inter-epidemic periods. We also observed that none of the Sb(5+)-unresponsivestains we analyzed was related to L. Tropica. Conclusions: We conclude that L. Donovani may be the causalagent for Indian kala-azar and that L. Tropica is most likely not an etiological agent for Indian Kala-azarcases that are unresponsive to antimonials.
Keywords: Bone Marrow - parasitology, DNA Primers, Drug Resistance, Electrophoresis, Cellulose Acetate, India, Isoenzymes - genetics, Leishmania donovani - enzymology, Leishmania donovani - genetics, Leishmania donovani - isolation & purification, Leishmania tropica - enzymology, Leishmania tropica - genetics, Leishmania tropica - isolation & purification, Leishmaniasis, Visceral - diagnosis, Leishmaniasis, Visceral - genetics, Leishmaniasis, Visceral - parasitology, Random Amplified Polymorphic DNA Technique, Spleen - parasitology, Bone Marrow - parasitology, DNA Primers, Drug Resistance, Electrophoresis, Cellulose Acetate, India, Isoenzymes - genetics, Leishmania donovani - isolation & purification, Leishmania tropica - isolation & purification, Leishmaniasis, Visceral - parasitology, Random Amplified Polymorphic DNA Technique, Spleen - parasitology
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Clinical Research
Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum HypertrophyMed Sci Monit In Press; DOI: 10.12659/MSM.947508
Clinical Research
Balancing Image Quality and Iodine Intake: Insights from CT Spectral Imaging of the Portal VeinMed Sci Monit In Press; DOI: 10.12659/MSM.947391
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Most Viewed Current Articles
17 Jan 2024 : Review article 7,160,485
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,385
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,806
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,071
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912